Search Medical Condition
Please enter condition
Please choose location from dropdown

Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Found (1765) clinical trials

Study schedule: -You will visit the study website and enter some demographic, health, and cognitive information. -If and when a research study that may be a good fit for you becomes available, you will be notified with information about how to sign up. Study activities may include: -Using the internet. …

Phase N/A

3.65 miles

Learn More »

Study schedule: -You will have two online sessions. Each session takes 20-40 minutes. -You will answer questions about your health. -You will do cognitive assessments. -If you use Apple HealthApp, you will be asked to give permission for data sharing. Study activities may include: -Completing online questionnaires about your health. …

Phase N/A

3.65 miles

Learn More »

Caregivers will participate in a 2-day caregiver training via zoom (3 hours each day). Caregivers and care recipients will take pre-tests (5-10 minutes each person), conduct one-hour life review session/per week for six weeks, and after the 6th week, will take the post-test (same as the pre-test). Caregivers will receive …

Phase

3.65 miles

Learn More »

Study activities include answering questions and completing activities over the phone and via computer.  

Phase N/A

3.65 miles

Learn More »

The study consists of filling in an online survey. The survey is made up of two sections, one to be completed by the person living with dementia (with or without help from a caregiver, it is your decision), and one to be completed by the informal caregiver. The questions include …

Phase N/A

3.65 miles

Learn More »

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy Surgery and/or Radiation Therapy

This is a randomized double-blind placebo-controlled phase III trial of aspirin (300 mg daily) in early stage node-positive HER2 negative breast cancer patients. Patients will be randomized 1:1 within stratum defined by: Hormone Receptor status (HR positive vs HR negative), body mass index (<30 vs 30 kg/m2) and stage (Stage …

Phase

4.02 miles

Learn More »

The HOPE Study: Characterizing Patients With Hepatitis B and C

Hepatitis B virus chronically infects 350 million people worldwide and over one million Americans and approximately 4.1 million individuals (1.6%) in the US population have been infected with hepatitis C. These infections are the leading cause of end-stage liver disease, cancer and indication for liver transplantation in the world. Both …

Phase N/A

4.02 miles

Learn More »

A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

A study of erdafitinib versus standard of care, consisting of chemotherapy (docetaxel or vinflunine) or anti-PD-(L) 1 agent pembrolizumab, in participants with advanced urothelial cancer and selected FGFR aberrations who have progressed on or after 1 or 2 prior treatments, at least 1 of which includes an anti-PD-(L) 1 agent …

Phase

4.1 miles

Learn More »

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

This is an interventional, non-randomized, controlled prospective study to treat HCV in mono-infected and HIV co-infected individuals and compare cardiovascular risk outcomes to HIV mono-infected controls. This pilot study will demonstrate whether functional cure of HCV reduces myocardial injury and risk of cardiovascular disease.

Phase

4.18 miles

Learn More »

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

The AtriCure CryoICE Ablation System is being studied to ablate cardiac tissue during surgery for the treatment of Persistent and Long-standing Persistent atrial fibrillation in open concomitant cardiac surgery. The effectiveness of the device will be demonstrated by establishing that the device effectively eliminates persistent and long-standing persistent atrial fibrillation …

Phase N/A

4.2 miles

Learn More »